Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,995,452
-$75,511,794 QoQ
Shares Held
99,402
-68.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#262
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2026CallValue
$72,424
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $2,303,425,127 across 13 Drug Manufacturers - General names. AMGN ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,989,537 | $759,252,709 | |
| 2 | ABBV |
AbbVie Inc.
|
2,990,512 | $752,532,439 | |
| 3 | LLY |
ELI LILLY & Co
|
334,637 | $401,373,688 | |
| 4 | AZN |
Astrazeneca PLC
|
841,164 | $159,501,517 | |
| 5 | NVO |
Novo Nordisk A S
|
1,707,104 | $81,838,564 | |
| 6 | NVS |
Novartis AG
|
330,061 | $51,727,159 | |
| 7 | AMGN |
Amgen Inc
This page
|
99,402 | $35,995,452 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
204,677 | $25,858,892 |
All Filings in AMGN
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,424 | 200 | Call | Other | 2026-08-13 | |
| 2026-06-30 | $35,995,452 | 99,402 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $105,555 | 300 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $35,185 | 100 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $111,507,246 | 316,917 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $32,355,248 | 98,852 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $15,577,500 | 50,000 | Put | Other | 2025-05-15 | |
| 2025-03-31 | $55,535,967 | 178,257 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,582,345 | 6,071 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $227,193,814 | 705,111 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $205,122,799 | 656,498 | Shares | Other | 2024-08-14 | |
| 2024-06-30 | $30,057,690 | 96,200 | Call | Other | 2024-08-14 | |
| 2024-03-31 | $137,451,659 | 483,440 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $39,470,548 | 137,041 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $416,101,756 | 1,548,228 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $47,955,653 | 215,997 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $4,689,950 | 19,400 | Call | Other | 2023-05-15 | |
| 2023-03-31 | $34,746,969 | 143,731 | Shares | Other | 2023-05-15 | |
| 2023-03-31 | $5,294,325 | 21,900 | Put | Other | 2023-05-15 | |
| 2022-12-31 | $15,587,946 | 59,351 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $17,933,725 | 79,564 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $62,826,871 | 258,228 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $77,365,471 | 319,930 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $23,602,727 | 104,915 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $605,839 | 2,849 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,449,318 | 42,869 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $15,531,964 | 62,425 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,615,569 | 11,376 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,446,170 | 5,690 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,886,396 | 71,595 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,004,121 | 4,953 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||